Merck KGaA (OTCMKTS:MKKGY – Get Free Report) reached a new 52-week low during trading on Thursday . The company traded as low as $28.96 and last traded at $29.08, with a volume of 139382 shares changing hands. The stock had previously closed at $29.31.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group assumed coverage on shares of Merck KGaA in a research report on Thursday, September 19th. They issued a “buy” rating on the stock.
Get Our Latest Report on Merck KGaA
Merck KGaA Trading Down 0.8 %
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
- Five stocks we like better than Merck KGaA
- What is a Death Cross in Stocks?
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.